These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [HLA typing in a neonate with posttransfusional graft vs host disease (PT-GVHD)]. Lista GL; Porcelli F; Mercuriali F; Farè M; Taccone F Pediatr Med Chir; 1994; 16(3):285-7. PubMed ID: 7971455 [TBL] [Abstract][Full Text] [Related]
3. [Transfusion-associated graft-versus-host disease guideline on gamma irradiation of blood components]. Landi EP; de Oliveira JS Rev Assoc Med Bras (1992); 1999; 45(3):261-72. PubMed ID: 10513059 [TBL] [Abstract][Full Text] [Related]
4. HLA homozygosity and shared HLA haplotypes in the development of transfusion-associated graft-versus-host disease. Shivdasani RA; Anderson KC Leuk Lymphoma; 1994 Oct; 15(3-4):227-34. PubMed ID: 7866271 [TBL] [Abstract][Full Text] [Related]
12. Transfusion associated graft versus host disease in an immunocompetent patient. O'Connor NT; Mackintosh P J Clin Pathol; 1992 Jul; 45(7):621-2. PubMed ID: 1517464 [TBL] [Abstract][Full Text] [Related]
13. Transfusion-associated graft-versus-host disease in immunocompetent patients: report of a fatal case associated with transfusion of blood from a second-degree relative, and a survey of predisposing factors. Petz LD; Calhoun L; Yam P; Cecka M; Schiller G; Faitlowicz AR; Herron R; Sayah D; Wallace RB; Belldegrun A Transfusion; 1993 Sep; 33(9):742-50. PubMed ID: 8105567 [TBL] [Abstract][Full Text] [Related]
14. Fatal transfusion-associated graft-versus-host disease in an immunocompetent recipient of a volunteer unit of red cells. Triulzi D; Duquesnoy R; Nichols L; Clark K; Jukic D; Zeevi A; Meisner D Transfusion; 2006 Jun; 46(6):885-8. PubMed ID: 16734803 [TBL] [Abstract][Full Text] [Related]
15. Transfusion-associated graft-versus-host disease and the irradiation of blood components. Davey RJ Immunol Invest; 1995; 24(1-2):431-4. PubMed ID: 7713602 [TBL] [Abstract][Full Text] [Related]
16. DNA-based HLA typing of nonhematopoietic tissue used to select the marrow transplant donor for successful treatment of transfusion-associated graft-versus-host disease. Friedman DF; Kwittken P; Cizman B; Argyris E; Kearns J; Yang SY; Zmijewski C; Bunin N; Douglas SD; Monos D Clin Diagn Lab Immunol; 1994 Sep; 1(5):590-6. PubMed ID: 8556506 [TBL] [Abstract][Full Text] [Related]